• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NALU MEDICAL INC NALU NEUROSTIMULATION SYSTEM; SPINAL CORD STIMULATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NALU MEDICAL INC NALU NEUROSTIMULATION SYSTEM; SPINAL CORD STIMULATOR Back to Search Results
Model Number 71005
Device Problem Migration (4003)
Patient Problem Inadequate Pain Relief (2388)
Event Date 11/20/2023
Event Type  Injury  
Manufacturer Narrative
The patient is reported as having a high bmi and the ipg was initially implanted in a location with very soft adipose tissue.Communication issues began approximately three months after implant, indicating the initial implant placement was acceptable and the ipg migrated after the procedure.Troubleshooting found that the device was able to be connected, however would disconnect frequently when the patient was seated in certain positions.Ability to connect and provide therapy indicates the system was functioning and there was no malfunction of the system or its components.Migration is a known inherent risk of implantable neuromodulation systems.
 
Event Description
Patient was implanted with the nalu spinal cord stimulator on (b)(6) 2023 targeting the thoracic nerve to treat lower back and leg pain.The implantable pulse generator (ipg) was placed in the lateral flank area and both intra-op and post-op testing was completed.Approximately three months after implant, the patient notified the firm of communication issues between the ipg and the external therapy discs and imaging confirmed the ipg had migrated within the pocket.Surgical revision was performed on (b)(6) 2023 to place a new ipg in a more superior and medial location and at a depth to avoid issues with weight fluctuation.Intra-op and post-op testing after the revision confirmed placement returned good connectivity.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NALU NEUROSTIMULATION SYSTEM
Type of Device
SPINAL CORD STIMULATOR
Manufacturer (Section D)
NALU MEDICAL INC
2320 faraday avenue
suite 100
calsbad CA 92008 2377
Manufacturer (Section G)
NALU MEDICAL, INC
2320 faraday ave
suite 100
carlsbad CA 92008 7241
Manufacturer Contact
terry villarba
2320 faraday avenue
suite 100
carlsbad, CA 92008-7241
7604482360
MDR Report Key18363852
MDR Text Key330989803
Report Number3015425075-2023-00320
Device Sequence Number1
Product Code GZB
UDI-Device Identifier00812537036137
UDI-Public01008125370361371122111817251118
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K183579
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 12/20/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/20/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number71005
Device Catalogue Number71005
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/20/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/18/2022
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-